The Analysis of MPM BioImpact LLC's Holdings
Currently, MPM BioImpact LLC holds 38 types of securities in its portfolio with a total value $874.0M. In the most recent quarter, they have increased their positions in LQDA (+1.2M shares, valued at $41.4M), AGIO (+1.3M shares, valued at $35.5M), QURE (+1.4M shares, valued at $33.1M); decreased their positions in SRPT (-630.0K shares, valued at $13.6M), RCKT (-2.3M shares, valued at $8.1M), CNTX (-4.0M shares, valued at $5.9M); initiated new positions in AGIO (+1.3M shares, valued at $35.5M), QURE (+1.4M shares, valued at $33.1M), ALMS (+2.4M shares, valued at $23.4M). Stock Holdings
TickerCompany NameSharesShares âŗ%Event DateReport DateHistory
CGEM Cullinan Therapeutics, Inc.7.6M shares0.00%2025-12-312026-02-17
MDGL Madrigal Pharmaceuticals Inc96.8K shares-3.62%2025-12-312026-02-17 LQDA Liquidia Corp1.4M shares600.43%2025-12-312026-02-17 TRVI Trevi Therapeutics Inc3.3M shares-3.52%2025-12-312026-02-17 EWTX Edgewise Therapeutics Inc1.7M shares-3.81%2025-12-312026-02-17 RVMD Revolution Medicines, Inc.505.7K shares60.16%2025-12-312026-02-17 AGIO Agios Pharmaceuticals Inc1.3M sharesnew addition2025-12-312026-02-17 QURE Uniqure NV1.4M sharesnew addition2025-12-312026-02-17 PTCT PTC Therapeutics Inc430.0K shares-1.93%2025-12-312026-02-17 SNDX Syndax Pharmaceuticals Inc1.3M shares-2.76%2025-12-312026-02-17 DYN Dyne Therapeutics, Inc.1.4M shares-2.83%2025-12-312026-02-17 TARS Tarsus Pharmaceuticals Inc328.9K shares-3.70%2025-12-312026-02-17 STOK Stoke Therapeutics Inc770.3K shares-2.46%2025-12-312026-02-17 ALMS Alumis Inc2.4M sharesnew addition2025-12-312026-02-17 URGN Urogen Pharma Ltd941.4K shares597.32%2025-12-312026-02-17 XENE Xenon Pharmaceuticals Inc485.6K shares-3.53%2025-12-312026-02-17 PVLA Palvella Therapeutics Inc205.7K shares205.16%2025-12-312026-02-17 NTRA Natera Inc93.6K shares-5.43%2025-12-312026-02-17 CRVS Corvus Pharmaceuticals Inc2.7M sharesnew addition2025-12-312026-02-17 RLAY Relay Therapeutics Inc.2.2M shares-2.20%2025-12-312026-02-17 GLUE Monte Rosa Therapeutics Inc1.2M sharesnew addition2025-12-312026-02-17 PTGX Protagonist Therapeutics Inc199.5K sharesnew addition2025-12-312026-02-17 CNTX Context Therapeutics Inc10.7M shares-27.38%2025-12-312026-02-17 ARQT Arcutis Biotherapeutics Inc531.2K sharesnew addition2025-12-312026-02-17 VTYX Ventyx Biosciences Inc1.6M sharesnew addition2025-12-312026-02-17 ORIC Oric Pharmaceuticals Inc1.8M shares4.01%2025-12-312026-02-17 BLTE Belite Bio Inc87.8K sharesnew addition2025-12-312026-02-17 CLYM Climb Bio Inc2.7M sharesnew addition2025-12-312026-02-17 ABVX Abivax SA56.3K sharesnew addition2025-12-312026-02-17 RCKT Rocket Pharmaceuticals, Inc.1.6M shares-59.37%2025-12-312026-02-17 MAZE Maze Therapeutics Inc81.1K sharesnew addition2025-12-312026-02-17 Evommune Inc Evommune Inc113.0K sharesnew addition2025-12-312026-02-17 SRPT Sarepta Therapeutics Inc70.0K shares-90.00%2025-12-312026-02-17 HOWL Werewolf Therapeutics, Inc.1.4M shares-42.15%2025-12-312026-02-17 Call Option Holdings
No call option holdings data available
Put Option Holdings
No put option holdings data available